Jump to Navigation
Trends and Sentiments
Comments and Analysis
Billions of noisy bugs are about to take the East Coast...
Chris Cuomo to Donald Trump: Even Chris Christie's...
How one simple mistake cost 'Real Housewives'...
This is Uber's secret weapon in its quest for world...
LIVE: Can team defy 5000-to-1 odds to win Premier League?
U.S Onshore Production Sees Deep Decline, Can Offshore...
Should Exxon Mobil Shareholders Be Worried About a...
Canfor Pulp Products' (CFPUF) CEO Don Kayne on Q1...
What The Heck Is Going On With The Dollar And 'Fear...
How To Compare FinTech Providers To Robo-Advisors
Good News for Vical Cancer Drug Candidate
Vical, Inc. Q4 2009 Earnings Call Transcript
Biotech Deal Activity Takes a Breather
7 Companies in the Race to Find Cures for Cancer
Vical Incorporated Q1 2010 Earnings Call Transcript
Vical Incorporated. Q2 2010 Earnings Call Transcript
Sanofi Failure Opens Door for Aastrom Bio
Bottom Fishing: Any Value in September's Losers?
15 Biotech Stocks With the Lowest Put/Call Ratios
Vical Analyst and Investor Day Transcript
Seven Stocks With CEO Buying in the Past Week
Vical CEO Discusses Q4 2010 Results - Earnings Call Transcript
18 Stocks on the 52 Week Low List Ready to Pop?
Ipilimumab Approval Highlights Active Immunotherapy Renaissance
Vical Is Deeply Undervalued: Technology and Pipeline Offer Upside Reward
Major FDA Approval Could Pave the Way for These 5 Biotechs
Vical: A Biotech Flying Under the Radar
Chinese CEOs: Cook Your Books at Your Own Peril
7 Dirt Cheap Biotech Stocks With Huge Upside
Breakouts: 6 Stocks Showing New Strength
Vical's CEO Discusses Q1 2011 Results - Earnings Call Transcript
4 Biotech Stocks with Extremely Bearish Options Sentiment
Personalized Medicine for the Masses
Careful Analysis Reveals Good Probability of Gains for Vical
Billions of noisy bugs are about to take the East...
This is Uber's secret weapon in its quest...
EUR/GBP: 1.2763 USD/EUR: 1.1447 JPY/USD: 106.3550
Bullfax.com - Market News & Analysis 2008-2011
Terms & Conditions